Relapsed or Refractory Primary Myelofibrosis
specificA primary myelofibrosis that is resistant to treatment.
11
Centers
11
Active Trials
—
Cancer Funding
Top Centers for Relapsed or Refractory Primary Myelofibrosis(11)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive Active Research Program | 54.5 |
| 2 | NCI Comprehensive Active Research Program | 54.5 |
| 3 | NCI Comprehensive Active Research Program | 54.5 |
| 4 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 54.5 |
| 5 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 54.5 |
| 6 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 54.5 |
| 7 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 54.5 |
| 8 | NCI Clinical Active Research Program | 54.5 |
| 9 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program | 54.5 |
| 10 | Boston University Cancer CenterBoston, MA Active Research Program | 54.5 |
| 11 | University of Cincinnati Cancer CenterCincinnati, OH Active Research Program | 54.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →